Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

Documenti analoghi

• The Difference of Clinical Characteristics Between Patients With Exon 19 Deletion and Those With L858R Mutation in Nonsmall Cell Lung Cancer
  di: Zhang, Yaxiong, et al.
  Pubblicazione: (2015)
• The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer
  di: Zhang, Yaxiong, et al.
  Pubblicazione: (2017)
• Comparison of clinicopathologic characteristics between patients with EGFR exon 19 deletion and EGFR L858R mutation in lung cancer
  di: Chen, Zhen, et al.
  Pubblicazione: (2018)
• The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs
  di: Tang, Yanna, et al.
  Pubblicazione: (2015)
• Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients
  di: Liang, Hengrui, et al.
  Pubblicazione: (2020)